Abstract
The biochemical basis of aging in general and of vascular aging in particular is the progressive failure of maintenance and repair systems due to cumulative molecular damage. One of the major sources of damage is reactive oxygen species (ROS). Indeed, all organisms living in an aerobic environment are exposed to ROS on a continual basis, generated as by-products of normal cellular metabolism and taken up from the external environment. In fact, oxidative damage is widely used as a biomarker of aging and diseases. At the cellular level, molecular damage and oxidative stress lead to cellular senescence. Endothelial senescent cells are proinflammatory, proatherosclerotic, and prothrombotic and could participate in the process of aging and atherosclerosis. ROS, however, also play a crucial role in physiologic cell function when present at a low physiologic concentration. Therefore, we believe that the exposure of the endothelium to physiologic oxidative stress during its maturation phase determines vascular longevity. This process is known as hormesis: mild stress activates different endogenous mechanisms of repair and maintenance to protect cells against subsequent stresses. In the case of endothelial cells, exposure to mild oxidative stress during the maturation phase of the endothelium will activate protective pathways involved in stress resistance. It is the cumulative and chronic stress that induce progressive failure of protective mechanisms, leading to higher susceptibility to diseases, cellular senescence, aging, and ultimately death.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300.
Bokov A, Chaudhuri A, Richardson A. The role of oxidative damage and stress in aging. Mech Ageing Dev. 2004;125:811–826.
Holliday R. Aging is no longer an unsolved problem in biology. Ann NY Acad Sci. 2006;1067:1–9.
Gems D, Partridge L. Stress-response hormesis and aging: “that which does not kill us makes us stronger”. Cell Metab. 2008;7:200–203.
Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res. 2005;66:286–294.
Hayflick L. “Anti-aging” is an oxymoron. J Gerontol A Biol Sci Med Sci. 2004;59:B573–B578.
Kirkwood TB. Understanding the odd science of aging. Cell. 2005;120:437–447.
Rattan SI. The science of healthy aging: genes, milieu, and chance. Ann NY Acad Sci. 2007;1114:1–10.
Rattan SI. Increased molecular damage and heterogeneity as the basis of aging. Biol Chem. 2008b;389:267–272.
Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol. 2007;292:R18–R36.
Medvedev ZA. An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc. 1990;65:375–398.
Walford RL. [Immunologic aspects of aging]. Klin Wochenschr. 1969;47:599–605.
d’Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer. 2008;8:512–522.
Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Res. 2007;35:7417–7428.
von Zglinicki T, Burkle A, Kirkwood TB. Stress, DNA damage and ageing – an integrative approach. Exp Gerontol. 2001;36:1049–1062.
Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann NY Acad Sci. 2006;1067:10–21.
Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95.
Tardif JC, Gregoire J, L’Allier PL, Ibrahim R, Anderson TJ, Reeves F, Title LM, Schampaert E, LeMay M, Lesperance J, Scott R, Guertin MC, Brennan ML, Hazen SL, Bertrand OF. Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial. Atherosclerosis. 2008;197:480–486.
Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation. 2002;105:2107–2111.
Cichowski K, Hahn WC. Unexpected pieces to the senescence puzzle. Cell. 2008;133:958–961.
Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol. 2005;37:961–976.
Chen J, Goligorsky MS. Premature senescence of endothelial cells: methusaleh’s dilemma. Am J Physiol Heart Circ Physiol. 2006;290:H1729–H1739.
Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay JW, Harley CB. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res. 1995;220:194–200.
Riethman H. Human telomere structure and biology. Annu Rev Genomics Hum Genet. 2008;9:1–19.
Shay JW, Wright WE. Hallmarks of telomeres in ageing research. J Pathol. 2007;211:114–123.
Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA. 1995;92:11190–11194.
Erusalimsky JD, Kurz DJ. Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol. 2005;40:634–642.
Toussaint O, Remacle J, Dierick JF, Pascal T, Frippiat C, Royer V, Chainiaux F. Approach of evolutionary theories of ageing, stress, senescence-like phenotypes, calorie restriction and hormesis from the view point of far-from-equilibrium thermodynamics. Mech Ageing Dev. 2002a;123:937–946.
Toussaint O, Remacle J, Dierick JF, Pascal T, Frippiat C, Zdanov S, Magalhaes JP, Royer V, Chainiaux F. From the Hayflick mosaic to the mosaics of ageing. Role of stress-induced premature senescence in human ageing. Int J Biochem Cell Biol. 2002b;34:1415–1429.
Cawthon RM, Smith KR, O’Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393–395.
Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet. 2001;358:472–473.
Farhat N, Thorin-Trescases N, Voghel G, Villeneuve L, Mamarbachi M, Perrault LP, Carrier M, Thorin E. Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers. Can J Physiol Pharmacol. 2008;86:761–769.
Voghel G, Thorin-Trescases N, Farhat N, Mamarbachi AM, Villeneuve L, Fortier A, Perrault LP, Carrier M, Thorin E. Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients. Mech Ageing Dev. 2008;129:261–270.
Voghel G, Thorin-Trescases N, Farhat N, Nguyen A, Villeneuve L, Mamarbachi AM, Fortier A, Perrault LP, Carrier M, Thorin E. Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors. Mech Ageing Dev. 2007;128:662–671.
Campisi J, d’Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729–740.
Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev. 2008;129:467–474.
Erusalimsky JD. Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol. 2009;106:326–332.
Minamino T, Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res. 2007;100:15–26.
Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363–9367.
Fenton M, Barker S, Kurz DJ, Erusalimsky JD. Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries. Arterioscler Thromb Vasc Biol. 2001;21:220–226.
Burrig KF. The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb. 1991;11:1678–1689.
Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM. Cellular senescence in aging primates. Science. 2006;311:1257.
Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev. 2007;128:36–44.
Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T, DePinho RA, Sharpless NE, Scadden DT. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature. 2006;443:421–426.
Chimenti C, Kajstura J, Torella D, Urbanek K, Heleniak H, Colussi C, Di Meglio F, Nadal-Ginard B, Frustaci A, Leri A, Maseri A, Anversa P. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res. 2003;93:604–613.
Altschul R. Endothelium, Its Development, Morphology, Function, and Pathology. MacMillan, New York, 1954.
Soberman RJ. The expanding network of redox signaling: new observations, complexities, and perspectives. J Clin Invest. 2003;111:571–574.
Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol. 2002;3:1129–1134.
Drouin A, Thorin-Trescases N, Hamel E, Falck JR, Thorin E. Endothelial nitric oxide synthase activation leads to dilatory H2O2 production in mouse cerebral arteries. Cardiovasc Res. 2007;73:73–81.
Faraci FM. Hydrogen peroxide: watery fuel for change in vascular biology. Arterioscler Thromb Vasc Biol. 2006;26:1931–1933.
Rhee SG. Cell signaling. H2O2, a necessary evil for cell signaling. Science. 2006;312:1882–1883.
Fratelli M, Goodwin LO, Orom UA, Lombardi S, Tonelli R, Mengozzi M, Ghezzi P. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc Natl Acad Sci USA. 2005;102:13998–14003.
Linnane AW, Eastwood H. Cellular redox regulation and prooxidant signaling systems: a new perspective on the free radical theory of aging. Ann NY Acad Sci. 2006;1067:47–55.
Madamanchi NR, Hakim ZS, Runge MS. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J Thromb Haemost. 2005;3:254–267.
Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol. 2004;122:339–352.
Fortuno A, San Jose G, Moreno MU, Diez J, Zalba G. Oxidative stress and vascular remodelling. Exp Physiol. 2005;90:457–462.
Gendron ME, Thorin E. A change in the redox environment and thromboxane A2 production precede endothelial dysfunction in mice. Am J Physiol Heart Circ Physiol. 2007;293:H2508–H2515.
Gendron ME, Thorin-Trescases N, Villeneuve L, Thorin E. Aging associated with mild dyslipidemia reveals that COX-2 preserves dilation despite endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2007;292:H451–H458.
Krummen S, Drouin A, Gendron ME, Falck JR, Thorin E. ROS-sensitive cytochrome P450 activity maintains endothelial dilatation in ageing but is transitory in dyslipidaemic mice. Br J Pharmacol. 2006;147:897–904.
Taylor R, Thoma K. Mortality patterns in the modernized Pacific Island nation of Nauru. Am J Public Health. 1985;75:149–155.
Zimmet PZ, Whitehouse S, Jackson L, Thoma K. High prevalence of hyperuricaemia and gout in an urbanised Micronesian population. Br Med J. 1978;1:1237–1239.
King H, Rewers M. Diabetes in adults is now a Third World problem. World Health Organization Ad Hoc Diabetes Reporting Group. Ethn Dis. 1993;3(Suppl):S67–S74.
Mattson MP. Hormesis defined. Ageing Res Rev. 2008b;7:1–7.
Calabrese EJ, Baldwin LA. Chemical hormesis: its historical foundations as a biological hypothesis. Toxicol Pathol. 1999;27:195–216.
Mattson MP. Hormesis and disease resistance: activation of cellular stress response pathways. Hum Exp Toxicol. 2008a;27:155–162.
Rattan SI. Hormesis in aging. Ageing Res Rev. 2008a;7:63–78.
Zhang Q, Pi J, Woods CG, Jarabek AM, Clewell HJ, Andersen ME. Hormesis and adaptive cellular control systems. Dose Response. 2008;6:196–208.
Lundblad V. DNA ends: maintenance of chromosome termini versus repair of double strand breaks. Mutat Res. 2000;451:227–240.
Radak Z, Chung HY, Goto S. Systemic adaptation to oxidative challenge induced by regular exercise. Free Radic Biol Med. 2008;44:153–159.
Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science. 1999;285:1390–1393.
Masoro EJ. The role of hormesis in life extension by dietary restriction. Interdiscip Top Gerontol. 2007;35:1–17.
Parsons PA. Life span: does the limit to survival depend upon metabolic efficiency under stress? Biogerontology. 2002;3:233–241.
Ji LL, Gomez-Cabrera MC, Vina J. Exercise and hormesis: activation of cellular antioxidant signaling pathway. Ann NY Acad Sci. 2006;1067:425–435.
Radak Z, Chung HY, Goto S. Exercise and hormesis: oxidative stress-related adaptation for successful aging. Biogerontology. 2005;6:71–75.
Goto S, Naito H, Kaneko T, Chung HY, Radak Z. Hormetic effects of regular exercise in aging: correlation with oxidative stress. Appl Physiol Nutr Metab. 2007;32:948–953.
Yokoo S, Furumoto K, Hiyama E, Miwa N. Slow-down of age-dependent telomere shortening is executed in human skin keratinocytes by hormesis-like-effects of trace hydrogen peroxide or by anti-oxidative effects of pro-vitamin C in common concurrently with reduction of intracellular oxidative stress. J Cell Biochem. 2004;93:588–597.
Hayflick L. Hormesis, aging and longevity determination. Hum Exp Toxicol. 2001;20:289–291, discussion 319–220.
Shama S, Kirchman PA, Jiang JC, Jazwinski SM. Role of RAS2 in recovery from chronic stress: effect on yeast life span. Exp Cell Res. 1998;245:368–378.
Toussaint O, Remacle J, Dierick JF, Pascal T, Frippiat C, Magalhaes JP, Chainaux F. Hormesis: a quest for virtuality? Hum Exp Toxicol. 2001;20:311–314, discussion 319–320.
Minois N. Applying hormesis in aging research and therapy: a commentary. Hum Exp Toxicol. 2001;20:309–310, discussion 319–320.
de Magalhaes JP, Church GM. Cells discover fire: employing reactive oxygen species in development and consequences for aging. Exp Gerontol. 2006;41:1–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LCC
About this chapter
Cite this chapter
Thorin-Trescases, N., Thorin, E. (2010). Vascular Aging and Oxidative Stress: Hormesis and Adaptive Cellular Pathways. In: Bondy, S., Maiese, K. (eds) Aging and Age-Related Disorders. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-602-3_15
Download citation
DOI: https://doi.org/10.1007/978-1-60761-602-3_15
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-601-6
Online ISBN: 978-1-60761-602-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)